Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Large-bore mechanical thrombectomy for pulmonary ...

Gilde Healthcare and Norwest co-led round to commercialize the Hēlo(R) Thrombectomy Platform MENLO PARK, Calif., April 7, 2026 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2"), a commercial-stage ...

The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy ...

California-based medtech E2 (Endovascular Engineering) has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment. | California-based medtech E2 ...

Penumbra (NYSE:PEN) today announced 90-day results from the landmark STORM-PE randomized trial of its thrombectomy technology ...

WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...

Please provide your email address to receive an email when new articles are posted on . A novel thrombectomy system beat safety and efficacy performance goals for treatment of patients with pulmonary ...

Long Beach, Calif. – May 3, 2024 – Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...

Women with pulmonary embolism (PE) who undergo percutaneous pulmonary artery thrombectomy have higher rates of morbidity and in-hospital mortality than men, a large, nationwide cohort study indicated.